Herbal use before and during pregnancy

American Journal of Obstetrics and Gynecology

Volumn 202, Issue 5, 2010, Pages 443.e1-443.e6

  Broussard, Cheryl S ^a,b   Louik, Carol ^c   Honein, Margaret A ^b   Mitchell, Allen A ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^c BOSTON UNIVERSITY   (United States)

Author keywords

drug safety; ephedra; herbal preparation; pregnancy

Indexed keywords

CRANBERRY EXTRACT; PEPPERMINT; PRIMROSE OIL;

AGE DETERMINATION; ARTICLE; CASE CONTROL STUDY; ECHINACEA; EDUCATIONAL STATUS; EPHEDRA; FIRST TRIMESTER PREGNANCY; GINGER; GINSENG; HERBAL MEDICINE; HUMAN; MATRICARIA; MEDICAL INFORMATION; NAUSEA AND VOMITING; POPULATION RESEARCH; PREGNANCY; PREPREGNANCY CARE; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; RASPBERRY; SOCIAL STATUS; TEA; TREATMENT DURATION; UNITED STATES;

EID: 77951877330     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.10.865     Document Type: Article

References (34)

1. Gardiner P., Kemper K.J., Legedza A., and Phillips R.S. Factors associated with herb and dietary supplement use by young adults in the United States. BMC Complement Altern Med 7 (2007) 39
2. Hepner D.L., Harnett M., Segal S., Camann W., Bader A.M., and Tsen L.C. Herbal medicine use in parturients. Anesth Analg 94 (2002) 690-693
3. Refuerzo J.S., Blackwell S.C., Sokol R.J., et al. Use of over-the-counter medications and herbal remedies in pregnancy. Am J Perinatol 22 (2005) 321-324
4. Tsui B., Dennehy C.E., and Tsourounis C. A survey of dietary supplement use during pregnancy at an academic medical center. Am J Obstet Gynecol 185 (2001) 433-437
5. Glover D.D., Amonkar M., Rybeck B.F., and Tracy T.S. Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol 188 (2003) 1039-1045
6. Eisenberg D.M., Davis R.B., Ettner S.L., et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280 (1998) 1569-1575
7. Leung J.M., Dzankic S., Manku K., and Yuan S. The prevalence and predictors of the use of alternative medicine in presurgical patients in five California hospitals. Anesth Analg 93 (2001) 1062-1068
8. Howell L., Kochhar K., Saywell Jr. R., et al. Use of herbal remedies by Hispanic patients: do they inform their physician?. J Am Board Fam Med 19 (2006) 566-578
9. US Food and Drug Administration Center for Food Safety and Applied Nutrition. Dietary Supplement Health and Education Act (DSHEA) of 2004. http://vm.cfsan.fda.gov/∼dms/dietsupp.html Accessed Dec. 2, 2008
10. Rados C. Ephedra ban: no shortage of reasons. FDA Consum 38 (2004) 6-7
11. National Institutes of Health Office of Dietary Supplements. Botanical dietary supplements: background information. Dietary supplement fact sheet. http://ods.od.nih.gov/factsheets/BotanicalBackground_pf.asp Accessed Oct. 30, 2008
12. Dugoua J.J., Mills E., Perri D., and Koren G. Safety and efficacy of ginkgo (Ginkgo biloba) during pregnancy and lactation. Can J Clin Pharmacol 13 (2006) e277-e284
13. Vickers A., and Zollman C. ABC of complementary medicine: herbal medicine. BMJ 319 (1999) 1050-1053
14. Saper R.B., Kales S.N., Paquin J., et al. Heavy metal content of ayurvedic herbal medicine products. JAMA 292 (2004) 2868-2873
15. Ko R.J. Adulterants in Asian patent medicines. N Engl J Med 339 (1998) 847
16. Allaire A.D., Moos M.K., and Wells S.R. Complementary and alternative medicine in pregnancy: a survey of North Carolina certified nurse-midwives. Obstet Gynecol 95 (2000) 19-23
17. Kelley K., Kelley T., Kaufman D., and Mitchell A. The Slone Drug Dictionary: a research driven pharmacoepidemiology tool. Pharmacoepidemiol Drug Saf 12 (2003) S168-S169
18. Hamilton B.E., Martin J.A., and Ventura S.J. Births: preliminary data for 2006 (2007), National Center for Health Statistics, National vital statistics reports. Hyattsville, MD 56-7
19. Cunningham F.G., Gant N.F., Leveno K.J., Gilstrap L.C., Hauth J.C., and Wenstrom K.D. Fetal growth and development. Williams obstetrics (2001), McGraw-Hill, New York 129-66
20. Kelly J.P., Kaufman D.W., Kelley K., Rosenberg L., Anderson T.E., and Mitchell A.A. Recent trends in use of herbal and other natural products. Arch Intern Med 165 (2005) 281-286
21. Moussally K., Oraichi D., and Berard A. Herbal products use during pregnancy: prevalence and predictors. Pharmacoepidemiol Drug Saf 18 (2009) 454-461
22. Holst L., Nordeng H., and Haavik S. Use of herbal drugs during early pregnancy in relation to maternal characteristics and pregnancy outcome. Pharmacoepidemiol Drug Saf 17 (2008) 151-159
23. Maats F.H., and Crowther C.A. Patterns of vitamin, mineral and herbal supplement use prior to and during pregnancy. Aust N Z J Obstet Gynaecol 42 (2002) 494-496
24. Yoon P.W., Rasmussen S.A., Lynberg M.C., et al. The National Birth Defects Prevention Study. Public Health Rep 116 suppl 1 (2001) 32-40
25. Holtzman D. The behavioral risk factor surveillance system. In: Blumenthal D.S., and DiClemente R.J. (Eds). Community-based health research: issues and methods (2004), Springer Publishing Co, Inc, New York 115-131
26. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey Questionnaire, 1999-2000. http://www.cdc.gov/nchs/nhanes/nhanes99_00.htm Accessed Nov. 18, 2009
27. Fein S.B., Labiner-Wolfe J., Shealy K.R., Li R., Chen J., and Grummer-Strawn L.M. Infant Feeding Practices Study II: study methods. Pediatrics 122 suppl 2 (2008) S28-S35
28. Werler M.M., Mitchell A.A., Hernandez-Diaz S., and Honein M.A. Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol 193 (2005) 771-777
29. Kaufman D.W., Kelly J.P., Rosenberg L., Anderson T.E., and Mitchell A.A. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 287 (2002) 337-344
30. National Children's Study Workshop. Use of herbal products in pregnancy, breastfeeding, and childhood. http://www.nationalchildrensstudy.gov/research/workshops/Pages/herbal_122003.aspx Accessed April 11, 2008
31. Mitchell A.A., Cottler L.B., and Shapiro S. Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol 123 (1986) 670-676
32. Harris I.M. Regulatory and ethical issues with dietary supplements. Pharmacotherapy 20 (2000) 1295-1302
33. Cogswell M., Bitsko R., Anderka M., et al. Control selection and participation in an ongoing, population-based, case-control study of birth defects, the National Birth Defects Prevention Study. Am J Epidemiol 170 (2009) 975-985
34. Friedman J.M. Teratology Society: presentation to the FDA public meeting on safety issues associated with the use of dietary supplements during pregnancy. Teratology 62 (2000) 134-137